Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
San Gabriel Valley Index
San Gabriel Valley
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
India Globalization Capital Inc
(NY:
IGC
)
0.4060
+0.0120 (+3.05%)
Official Closing Price
Updated: 8:00 PM EDT, Aug 21, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about India Globalization Capital Inc
< Previous
1
2
...
10
11
12
13
14
15
16
17
Next >
IGC Reports Financial Results for the Quarter Ended June 30, 2022
August 08, 2022
From
India Globalization Capital, Inc.
Via
Business Wire
IGC Revenue Drops 55.8% In Fiscal 2022, What About Gross Profit?
June 23, 2022
India Globalization Capital, Inc. (AMEX:IGC) revenue in fiscal 2022 was $397,000, a 55.8% decrease compared to $898,000 in fiscal 2021.
Via
Benzinga
IGC Reports Financial Results for Fiscal Year Ended March 31, 2022
June 22, 2022
From
India Globalization Capital, Inc.
Via
Business Wire
IGC Acquires Exclusive Rights For A Potential Alzheimer's Drug Development Candidate
June 21, 2022
One of subsidiaries of India Globalization Capital, Inc. (NYSE: IGC) reached an intellectual property license agreement for a potential Alzheimer’s drug development candidate.
Via
Benzinga
The Future Of The Indian Market
June 19, 2022
India has an estimated 26,000 startups, making it the third-largest startup ecosystem in the world, recording consolidated inflows of over $36 billion in the past 3 years.
Via
Talk Markets
IGC Acquires Exclusive Rights for a Potential Alzheimer’s Drug Development Candidate
June 21, 2022
From
India Globalization Capital, Inc.
Via
Business Wire
91 Biggest Movers From Friday
June 13, 2022
Gainers RISE Education Cayman Ltd (NYSE: REDU) shares jumped 138.5% to settle at $3.41 on Friday. RISE Education announced expected timing for the completion of the merger with Dada Auto.
Via
Benzinga
44 Stocks Moving In Friday's Mid-Day Session
June 10, 2022
Gainers Cogent Biosciences, Inc. (NASDAQ: COGT) shares jumped 77% to $8.79 after the company reported initial data from its ongoing Phase 2 APEX clinical trial.
Via
Benzinga
36 Stocks Moving In Thursday's Mid-Day Session
June 09, 2022
Gainers Powerbridge Technologies Co., Ltd. (NASDAQ: PBTS) jumped 65% to $0.6382.
Via
Benzinga
69 Biggest Movers From Yesterday
June 10, 2022
Gainers Powerbridge Technologies Co., Ltd. (NASDAQ: PBTS) shares climbed 189.9% to close at $1.12 on Thursday.
Via
Benzinga
IGC Receives U.S. Patent For Method And Composition For Treating Seizure Disorders, Utilizing CBD
June 09, 2022
United States Patent and Trademark Office issued a patent (#11,351,152) to the India Globalization Capital, Inc. (AMEX:IGC) titled “Method and Composition for Treating Seizure Disorders.”
Via
Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday
June 09, 2022
Good morning! We're starting off another day of trading with an overview of the biggest pre-market stock movers for Thursday!
Via
InvestorPlace
18 Stocks Moving in Thursday's Pre-Market Session
June 09, 2022
Gainers View, Inc. (NASDAQ: VIEW) rose 18.5% to $2.05 in pre-market trading after declining 5% on Wednesday.
Via
Benzinga
IGC Receives U.S. Patent for Method and Composition for Treating Seizure Disorders
June 08, 2022
From
India Globalization Capital, Inc.
Via
Business Wire
83 Biggest Movers From Yesterday
June 09, 2022
Gainers Symbotic Inc. (NASDAQ: SYM) shares surged 120.6% to settle at $20.07 on Wednesday. Symbotic reported the completion of its business combination with SVF Investment Corp. to become a publicly...
Via
Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday
June 03, 2022
Good morning! We're preparing for another busy day of trading with a breakdown of the biggest pre-market stock movers for Friday!
Via
InvestorPlace
India Globalization Capital, Inc. (IGC) Announces Final Approval of Settlement of Shareholder Class Action Lawsuits
April 18, 2022
From
India Globalization Capital, Inc.
Via
Business Wire
36 Stocks Moving In Friday's Mid-Day Session
March 25, 2022
Gainers Forge Global Holdings, Inc. (NYSE: FRGE) shares jumped 66.4% to $20.70. Clever Leaves Holdings Inc. (NASDAQ: CLVR) jumped 29.1% to $2.04 after the company reported...
Via
Benzinga
64 Biggest Movers From Friday
March 28, 2022
Gainers Clever Leaves Holdings Inc. (NASDAQ: CLVR) shares surged 143% to settle at $3.84 on Friday after the company reported better-than-expected Q4 sales results and reaffirmed...
Via
Benzinga
34 Stocks Moving in Friday's Pre-Market Session
March 25, 2022
Gainers Clever Leaves Holdings Inc. (NASDAQ: CLVR) rose 40.5% to $2.22 in pre-market trading after the company reported better-than-expected Q4 sales results and reaffirmed FY22...
Via
Benzinga
Cannabis Stocks That Moved On News That Federal Cannabis Legalization Bill Heads To House For Vote Next Week
March 24, 2022
The House of Representatives intends to vote on a bill to federally legalize cannabis for the second time in history next week, congressi...
Via
Benzinga
India Globalization Capital Appoints Claudia Grimaldi to its Board of Directors
March 23, 2022
From
India Globalization Capital, Inc.
Via
Business Wire
India Globalization Capital Posts Net Loss Of $2.38M For The Third Quarter
February 11, 2022
India Globalization Capital, Inc. (AMEX:IGC) announced its financial results for the three months ending December 31, 2021 – quarter three of the company’s 2022 fiscal year. Q3 Financial Highlights
Via
Benzinga
IGC Reports Financial Results for the December 31, 2021 Quarter
February 10, 2022
From
India Globalization Capital, Inc.
Via
Business Wire
India Globalization Capital Appoints Former Congressman Jim Moran to Its Board of Directors
January 19, 2022
From
India Globalization Capital, Inc.
Via
Business Wire
IGC THC-Drug For Alzheimer's Symptoms Proved Safe & Effective, Pending FDA Approval For More Trials
December 14, 2021
India Globalization Capital, Inc. (NYSE: IGC) announced Tuesday that it had received positive primary endpoint data for its Phase 1 clinical trial for IGC-AD1, which is a...
Via
Benzinga
Clinical Trial on Alzheimer’s Patients Indicates Positive Safety and Tolerability Data for IGC’s THC-Based Investigational New Drug
December 14, 2021
From
India Globalization Capital, Inc.
Via
Business Wire
IGC Trials Research Effective THC Drug Dosing For Alzheimer's Patients
December 09, 2021
India Globalization Capital, Inc. (AMEX:IGC) revealed th...
Via
Benzinga
Phase 1 Clinical Trial Provides Valuable Insights on Safe and Effective Dosing of IGC-AD1 for Alzheimer’s Patients
December 08, 2021
From
India Globalization Capital, Inc.
Via
Business Wire
Phase 1 Clinical Trial Data Indicate IGC’s THC-based Investigational New Drug May Reduce Symptoms of Dementia in Alzheimer’s Patients
December 02, 2021
From
India Globalization Capital, Inc.
Via
Business Wire
< Previous
1
2
...
10
11
12
13
14
15
16
17
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.